Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial therapy issues facing pediatricians

J O Klein1

  • 1Department of Pediatrics, Boston University School of Medicine, Boston City Hospital, MA, USA.

The Pediatric Infectious Disease Journal
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic needle aspiration in pediatric practice. With special reference to lungs, middle ear, urinary bladder, and amniotic cavity.

Pediatric clinics of North America·2015
Same author

In vitro Activity of Selected Cephalosporins and Penicillins against Bacteria of Importance in Infections of Infants and Children.

Proceedings of the Royal Society of Medicine·2010
Same author

Otitis media: a preventable disease? Proceedings of an international symposium organized by the Marcel Mérieux Foundation, Veyrier-du-Lac, France, February 13 to 16, 2000.

The Pediatric infectious disease journal·2001
Same author

Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.

The Pediatric infectious disease journal·2001
Same author

The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.

The Pediatric infectious disease journal·2001
Same journal

A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings.

The Pediatric infectious disease journal·2026
Same journal

Model-based Differentiation Between Kawasaki Disease and MIS-C: The Importance of the Mitral Valve.

The Pediatric infectious disease journal·2026
Same journal

Pulmonary Embolism in Invasive Salmonella Infection: A Rare Cause of Acute Respiratory Failure in an Adolescent.

The Pediatric infectious disease journal·2026
Same journal

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same journal

Determinants of Severity in Pediatric Viral Lower Respiratory Tract Diseases From Emergency Department Presentation to Hospital Course.

The Pediatric infectious disease journal·2026
Same journal

Oropharyngeal Colonization by Kingella kingae and Septic Arthritis in Children 6-48 Months of Age: A Portuguese Multicenter Case-control Study.

The Pediatric infectious disease journal·2026
See all related articles

Emerging antimicrobial resistance in Streptococcus pneumoniae and Haemophilus influenzae necessitates updated treatment guidelines for infectious diseases. Understanding changing pathogen susceptibility is crucial for effective patient care and drug development.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • The field of infectious diseases is dynamic, with evolving pathogens, antimicrobial resistance, and diagnostic/therapeutic advancements.
  • Increasing resistance of Streptococcus pneumoniae to antimicrobials and the rise of beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis are significant clinical concerns.
  • Changes in antimicrobial susceptibility patterns require continuous monitoring and adaptation of treatment strategies.

Purpose of the Study:

  • To highlight recent changes and challenges in the field of infectious diseases.
  • To discuss the implications of altered antimicrobial susceptibility patterns for common bacterial pathogens.
  • To underscore the need for updated therapeutic approaches and rigorous evaluation of new drugs and treatment strategies.

Related Experiment Videos

Main Methods:

  • Review of current trends in infectious disease emergence and pathogen characteristics.
  • Analysis of antimicrobial susceptibility data for key bacterial pathogens like Streptococcus pneumoniae and Haemophilus influenzae.
  • Discussion of clinical implications and therapeutic considerations based on evolving resistance patterns.

Main Results:

  • Decreased antibiotic susceptibility in Streptococcus pneumoniae is a growing issue in the United States.
  • Optimal therapy for pneumococcal disease depends on local susceptibility patterns.
  • Group A streptococci remain susceptible to penicillins and cephalosporins, but concerns exist regarding rheumatic fever and severe invasive disease.

Conclusions:

  • The changing ecology of Streptococcus and implications for therapy require careful consideration.
  • New diagnostic techniques, drugs, and vaccines are essential to combat emerging infectious disease threats.
  • Evidence-based guidelines and rigorous study designs are crucial for evaluating new antimicrobial agents and treatment protocols, especially for conditions like acute bacterial otitis media in children.